Telehealth Founder Sentenced for Distributing 37 Million Adderall Pills

Thirty-seven million pills. Say that number out loud and it stops sounding like a business model and starts sounding like a supply chain problem for a drug cartel that happened to incorporate in Delaware instead of operating out of a jungle. Ruthia He built Done Global on the pandemic-era promise that telehealth would expand access to care, and instead she turned it into an Adderall vending machine with an app attached. Six years and a $1 million fine for defrauding insurers of $12 million and running a stimulant pipeline of that size is not exactly a stiff price of doing business.

This is the part of the telehealth boom nobody wanted to talk about while everyone was busy praising Zoom doctors as the future of medicine. Regulators loosened prescribing rules during COVID so people stuck at home could still get care, and that was a reasonable call at the time. But reasonable exceptions have a way of becoming permanent loopholes the moment someone figures out how to monetize them at scale. He didn't stumble into this. She built the technology specifically to make mass prescribing fast, easy, and hard to trace back to any single doctor actually laying eyes on a patient.

The obstruction charge is the tell. People who think they're running a legitimate, if aggressive, business don't go out of their way to interfere with a federal investigation. That's the behavior of someone who understood exactly what she was doing and knew what it would look like from the outside.

We keep hearing that Silicon Valley disruption is going to fix healthcare. Sometimes it does. But "disrupting" prescribing standards for a controlled substance isn't innovation, it's just old-fashioned drug diversion wearing a hoodie and calling itself a startup. The sentence should be a warning to every founder chasing growth metrics in a business that touches human bodies: move fast and break things works fine for photo apps. It does not work for Adderall.